TY  - JOUR

T1  - Is intention to treat still the gold standard or should health technology assessment agencies embrace a broader estimands framework? : Insights and perspectives from the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum

JO  - Value in Health

PY  - 2022/09/21

AU  - Morga A

AU  - Latimer NR

AU  - Scott M

AU  - Hawkins N

AU  - Schlichting M

AU  - Wang J

ED  - 

DO  - DOI: 10.1016/j.jval.2022.08.008

PB  - Elsevier BV

Y2  - 2024/12/22

ER  -